Following on from our recent webinar on Achieving EMA policy 0070 compliance (click here to view the full recording), we’ve created a step-by-step guide to help organisations create a process to efficiently complete any data anonymisation project.
Under EMA Policy 0070, your organisation must prepare anonymised versions of clinical reports so that subjects cannot be re-identified, while retaining the data’s value for independent secondary analyses. This is not just a requirement for European organisations. In the US, the FDA is taking similar steps now too, with the launch of a new pilot initiative around clinical study reports.
Read the infographic below and learn how your organisation can use our best practices to develop a systematic solution.